Pure Global
NCT05223881

Gastroparesis in Cystic Fibrosis

13^C-Spirulina Platensis Gastric Emptying Breath Test for Diagnosis of Gastroparesis in Patients With Cystic Fibrosis
University of Miami·ClinicalTrials.gov·device·Device trialWithdrawn
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Gastroparesis
Drug/Device/Intervention
13^C Spirulina Platensis Gastric Emptying Breath Test (GEBT)
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
University of Miami
Timeline & enrollment
Phase
N/A
Start date
Feb 14, 2022
End date
Mar 30, 2023
Enrollment
0 participants
Primary outcome

Rate of gastric emptying

Summary

The purpose of this research is to determine if an investigational device called the
 13C-Spirulina Gastric Emptying Breath Test (GEBT), can accurately diagnose gastroparesis
 (delayed emptying of the stomach) in patients with Cystic Fibrosis (CF).

ICD-10 classifications
Attention to gastrostomyGastrostomy statusOther gastritisGastritis, unspecifiedGastric diverticulum
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT05223881
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT05223881 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Miami and is currently Withdrawn. The study focuses on Gastroparesis. Target enrollment is 0 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.